The Avalanche is coming… and just now it’s starting to snow.

The Avalanche is coming… and just now it’s starting to snow.

Bibliographic Details
Main Authors:	Richard eAspinall, Pierre Olivier eLang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2013-06-01
Series:	Frontiers in Immunology
Subjects:	Immunity, Cellular Vaccination Ageing influenza Demographics
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fimmu.2013.00165/full

Similar Items

Inﬂuenza and Memory T Cells: How to Awake the Force
by: Jan Spitaels, et al.
Published: (2016-10-01)

Humoral and cellular immune responses after influenza vaccination in patients with chronic fatigue syndrome
by: Prinsen Hetty, et al.
Published: (2012-12-01)

DNA Vaccine Expressing Conserved Influenza Virus Proteins Protective Against H5N1 Challenge Infection in Mice
by: Suzanne L. Epstein, et al.
Published: (2002-08-01)

Equine Influenza Virus and Vaccines
by: Fatai S. Oladunni, et al.
Published: (2021-08-01)

POTENTIAL OF THE RUSSIAN FEDERATION IN EXPORTS OF ANTI-INFLUENZA VACCINES IN LATIN AMERICAN COUNTRIES
by: V. P. Trukhin, et al.
Published: (2019-01-01)

Broadly Protective Strategies Against Influenza Viruses: Universal Vaccines and Therapeutics
by: Olivia A. Vogel, et al.
Published: (2020-02-01)

Measuring Cellular Immunity to Influenza: Methods of Detection, Applications and Challenges
by: Lynda Coughlan, et al.
Published: (2015-04-01)

Revisiting Influenza Vaccination Exemption
by: Margaret Ryan, et al.
Published: (2018-10-01)

Progress in the Development of Universal Influenza Vaccines
by: Wenqiang Sun, et al.
Published: (2020-09-01)

OVX836 Heptameric Nucleoprotein Vaccine Generates Lung Tissue-Resident Memory CD8+ T-Cells for Cross-Protection Against Influenza
by: Judith Del Campo, et al.
Published: (2021-06-01)

Influenza Virus and Vaccination
by: Aitor Nogales, et al.
Published: (2020-03-01)

Using the 4 pillars™ practice transformation program to increase adult influenza vaccination and reduce missed opportunities in a randomized cluster trial
by: Chyongchiou J. Lin, et al.
Published: (2016-11-01)

Baseline CD3+CD56+ (NKT-like) Cells and the Outcome of Influenza Vaccination in Children Undergoing Chemotherapy
by: Evelin A. Leibinger, et al.
Published: (2021-06-01)

Immunogenicity of Influenza Vaccines: Evidence for Differential Effect of Secondary Vaccination on Humoral and Cellular Immunity
by: Sietske K. Rosendahl Huber, et al.
Published: (2019-01-01)

Developing Universal Influenza Vaccines: Hitting the Nail, Not Just on the Head
by: Lidewij C. M. Wiersma, et al.
Published: (2015-03-01)

Vaccination against influenza in elderly people: factors associated with acceptance and refusal of the vaccine
by: Cristiano José Mendes Pinto, et al.
Published: (2019-03-01)

Influenza Vaccination: A Cross-Sectional Survey of Knowledge, Attitude and Practices among the Lebanese Adult Population
by: Ghada El Khoury, et al.
Published: (2015-12-01)

The Nature of Immune Responses to Influenza Vaccination in High-Risk Populations
by: Kristin B. Wiggins, et al.
Published: (2021-06-01)

Effectiveness of influenza vaccine in aging and older adults: comprehensive analysis of the evidence
by: Lang PO, et al.
Published: (2012-02-01)

Can We Translate Vitamin D Immunomodulating Effect on Innate and Adaptive Immunity to Vaccine Response?
by: Pierre Olivier Lang, et al.
Published: (2015-03-01)

Awareness of Influenza and Pneumococcal Vaccination in the Geriatric Age Group
by: Süheyla AYDOĞMUŞ, et al.
Published: (2010-12-01)

Randomized Quality Improvement Trial of Opting-In Versus Opting-Out to Increase Influenza Vaccination Rates during Pregnancy
by: Susan H. Wootton, et al.
Published: (2018-07-01)

Development of cross-protective influenza A vaccines based on cellular responses
by: Peter Christiaan Soema, et al.
Published: (2015-05-01)

REACTOGENITY OF TICK-BORNE ENCEPHALITIS VACCINE ENCEPUR ADULT AND IMMUNE RESPONSE
by: G. N. Leonova, et al.
Published: (2014-07-01)

Pregnancy Downregulates Plasmablast Metabolic Gene Expression Following Influenza Without Altering Long-Term Antibody Function
by: Dominika Swieboda, et al.
Published: (2020-08-01)

CROSSREACTIVE ANTIBODIES AND MEMORY T CELLS TO HUMAN AND ZOONOTIC INFLUENZA A VIRUSES IN VOLUNTEERS
by: I. V. Losev, et al.
Published: (2015-10-01)

Pandemic Influenza Vaccines: What did We Learn from the 2009 Pandemic and are We Better Prepared Now?
by: Steven Rockman, et al.
Published: (2020-05-01)

Regulation of cell-mediated immunity during reinfection with influenza virus /
by: Beck, Melinda Annetta
Published: (1987)

Pathogenic Responses among Young Adults during the 1918 Influenza Pandemic
by: G. Dennis Shanks, et al.
Published: (2012-02-01)

T cell immunity to influenza in older adults: A pathophysiological framework for development of more effective vaccines
by: Janet E McElhaney, et al.
Published: (2016-02-01)

Vaccination coverage rate in children from birth to 24 months ( Semnan, 1994)
by: Ahadi F.
Published: (1999-06-01)

Influenza Vaccination Strategies: Comparing Inactivated and Live Attenuated Influenza Vaccines
by: Saranya Sridhar, et al.
Published: (2015-04-01)

The development of Kangiqsualujjuaq and the threat of snow avalanches in a permafrost degradation context, Nunavik, Canada
by: Armelle Decaulne, et al.
Published: (2021-01-01)

Bordetella bronchiseptica Colonization Limits Efficacy, but Not Immunogenicity, of Live-Attenuated Influenza Virus Vaccine and Enhances Pathogenesis After Influenza Challenge
by: Holly R. Hughes, et al.
Published: (2018-10-01)

SYSTEMIC ANTIBODY AND CELLULAR IMMUNE RESPONSES IN INFLUENZA INFECTION AND POSTSVACCINATION
by: S. A. Donina, et al.
Published: (2014-07-01)

Partial Immunities: Rethinking Communities and Belonging through Viral Memories of Influenza
by: Venla Oikkonen
Published: (2018-09-01)

Influenza vaccine efficacy in patients aged 60–75 years in the 2016/2017 season
by: Agata Sławin, et al.
Published: (2018-09-01)

Immune Responses to Pandemic H1N1 Influenza Virus Infection in Pigs Vaccinated with a Conserved Hemagglutinin HA1 Peptide Adjuvanted with CAF<sup>®</sup>01 or CDA/αGalCerMPEG
by: Sergi López-Serrano, et al.
Published: (2021-07-01)

Immunogenicity and protective efficacy of prime-boost immunization in mice vaccinated with live and inactivated influenza A (H5N1) vaccines
by: I. Losev, et al.
Published: (2019-05-01)

Intranasal vaccination with an engineered influenza virus expressing the receptor binding subdomain of botulinum neurotoxin provides protective immunity against botulism and influenza
by: Junwei eLi, et al.
Published: (2015-04-01)